Before the presidential debate between former President Donald Trump and President Joe Biden amped up the discussion about mental fitness, voters were already asking how old is too old to be president ...
President Joe Biden should undergo “detailed cognitive and movement disorder testing” and share the results of those tests with the public, CNN’s chief medical correspondent says. Sanjay Gupta, a ...
Opinion
The New Republic on MSNOpinion
Cognitive Tests Are Good. The Way Trump Talks About Them Is Bad.
Trump gets a lot of things wrong when he talks about cognitive tests. He recently bragged to journalists that he “aced” one, and said the doctors at Walter Reed told him no president had taken a ...
Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...
It seemed like a sensible suggestion for assessing the capabilities of an 81-year-old man seeking voters’ approval to remain in the White House until January 2029. To reassure the American people, ABC ...
CNN chief medical correspondent Dr. Sanjay Gupta called for President Biden to undergo neurological testing so that the American people can find out if he has dementia ahead of the 2024 election. In ...
The Montreal Cognitive Assessment is a 30-point exam meant to screen for Alzheimer's and other cognitive impairments in older adults.
A cognitive test is a required part of the Medicare annual wellness visit (AWV). This can be a valuable tool in discovering specific cognitive health conditions early, like dementia and Alzheimer’s ...
MedPage Today on MSN
What Trump's cognitive tests can -- and can't -- reveal
Trump's first presidential cognitive assessment was in 2018, when he took the Montreal Cognitive Assessment (MoCA) -- a brief 30-point cognitive screening tool designed to detect mild cognitive ...
Cancer related cognitive impairment in patients can stem from the cancer itself as well as the therapies used to treat it.
RESEARCHERS have identified p-tau217 as a powerful prognostic marker for cognitive impairment in people with idiopathic REM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results